Acute Cholangitis
10
1
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis
Impact of Positive Bile Cultures on Plastic Biliary Stent Exchange
Urgent (<24 Hours) Versus Early (24 to 48 Hours) ERCP for Patients With Mild and Moderate Acute Cholangitis
The Necessity of Bile Cultures in Patients With Acute Cholangitis
Modified Laparoscopic Transcystic Biliary Drainage in the Management of Cholecystocholedocholithiasis
Visualization of the Extrahepatic biliaRy Tree Trial
Short Duration Versus Fourteen Days Antibiotic in Common Bile Duct Cholangitis
Is Short Antibiotherapy Duration After Drainage Suitable for Patients Admitted in Intensive Care Medicine With a Severe Acute Cholangitis?
Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study
Transient ECG Changes in Patients With Acute Biliary Disease